1l-Ianda S. Newer trends in the management of psoriasis at diffi- cult to treat locations: scalp, palmoplantar disease and nails[J]. Indian J Dermatol Venereol Leprol [J]. 2010, 76(6): 634-644.
2Menter A, Korman N J, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoria-sis with topical therapies [J]. J Am Acad Dermatol. 2009, 60(4): 643 -659.
4Furne M, YoichiKohno, Yamamoto S, et al. Therapeutic Guidelines for Atopic Dermatitis 2002. Allergology International, 2005, 54 ( 1 ) : 45-49.
5Brazzini B, Pimpinelli N. New and established topieal corticosteroids in dermatology: clinieal pharmacology and therapeutic use. Am J Clin Dermatol, 2002, 3 (1): 47-58.
6Scheman A J, David L, et al. Adapted from Pocket Guide to medication used in Dermatology. Andrew Severson-Sth Edition, 1997.
7Wozniacka A, Sysa-Jedrzejowska A. Topical steroids-a new approach after 50 years. Med Sci Monit, 2001, 7(3): 539-544.
8Prakash A, Benfield P. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs, 1998, 55 (1): 145-163.
9Sehnopp C, Hohmann C, Stock S, et al. Topical steroids under wet-wrap dressings in atopie dermatitis--a vehicle-controlled trial. Dermatology, 2002, 204( 1 ): 56-59.
10Furue M, Terao H, Rikihisa W, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol, 2003, 148( 1 ): 128-133.
